Mankind Pharma Limited has informed the Exchange regarding Board meeting held on April 14, 2025.
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma Limited has informed the stock exchange that its Board of Directors held a meeting on April 14, 2025. This is a standard corporate disclosure filed under SEBI listing regulations, which require companies to notify exchanges whenever a board meeting takes place. The filing itself does not mention any specific agenda items, decisions, or outcomes from the meeting in the headline. Shareholders typically wait for the detailed outcome filing to know what was approved or discussed.
This is a routine disclosure and usually has no immediate impact on the stock price. Investors should look for a follow-up filing detailing the decisions made at the meeting, which could include matters like quarterly results, dividend announcements, fundraising, or other corporate actions.